- Home
- BMRN vs ULS Comparison
BMRN vs ULS Comparison
Compare BMRN & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | ULS |
|---|---|---|
| Founded | 1996 | 1894 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 14.5B |
| IPO Year | 1999 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BMRN | ULS |
|---|---|---|
| Price | $56.34 | $73.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 13 |
| Target Price | $91.59 | ★ $96.57 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 10-30-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.77 | ★ 1.66 |
| Revenue | $1,313,646,000.00 | ★ $3,053,000,000.00 |
| Revenue This Year | $21.42 | $5.47 |
| Revenue Next Year | $14.51 | $7.58 |
| P/E Ratio | $70.97 | ★ $43.85 |
| Revenue Growth | ★ 17.62 | 6.38 |
| 52 Week Low | $49.26 | $63.17 |
| 52 Week High | $70.98 | $107.54 |
Technical Indicators
Market Signals| Indicator | BMRN | ULS |
|---|---|---|
| Relative Strength Index (RSI) | 31.35 | 58.82 |
| Support Level | $53.61 | $68.50 |
| Resistance Level | $57.95 | $73.62 |
| Average True Range (ATR) | 1.42 | 2.19 |
| MACD | -0.06 | 1.04 |
| Stochastic Oscillator | 11.06 | 81.23 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.